{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T22:16:33Z","timestamp":1783203393125,"version":"3.54.6"},"reference-count":233,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006289","name":"Electricity France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"French National Research Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.radonc.2026.111570","type":"journal-article","created":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T05:45:12Z","timestamp":1778391912000},"page":"111570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Non-coding (nc) RNAs and breast cancer treatment related sequelae: Current evidence and perspectives"],"prefix":"10.1016","volume":"220","author":[{"given":"Juliette","family":"Montanari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0189-0573","authenticated-orcid":false,"given":"Tatiana","family":"Vinasco-Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0898-1582","authenticated-orcid":false,"given":"Gilles","family":"Lema\u00eetre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8114-5900","authenticated-orcid":false,"given":"Guillaume","family":"Vogin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8702-247X","authenticated-orcid":false,"given":"Nicolas O.","family":"Fortunel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2026.111570_b0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA A Cancer J Clinicians"},{"key":"10.1016\/j.radonc.2026.111570_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106535","article-title":"Breast cancer: Biology, biomarkers, and treatments","volume":"84","author":"Barzaman","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.radonc.2026.111570_b0015","first-page":"20","volume":"6","author":"Nagarajan","year":"2018","journal-title":"Immune Landscape of Breast Cancers Biomedicines"},{"key":"10.1016\/j.radonc.2026.111570_b0020","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","volume":"121","author":"Lehmann","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.radonc.2026.111570_b0025","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jama.2018.19323","article-title":"Breast Cancer Treatment: a Review","volume":"321","author":"Waks","year":"2019","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.radonc.2026.111570_b0030","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/cncr.35019","article-title":"Burden of late effects in a nationwide sample of long-term breast cancer survivors","volume":"130","author":"Smedsland","year":"2024","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2026.111570_b0035","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/jamaoncol.2015.2639","article-title":"Validity and Reliability of the US National Cancer Institute\u2019s Patient-Reported Outcomes Version of the Common Terminology Criteria for adverse events (PRO-CTCAE)","volume":"1","author":"Dueck","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2026.111570_b0040","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.2196\/jmir.1223","article-title":"An Internet Tool for Creation of Cancer Survivorship Care Plans for Survivors and Health Care Providers: Design, Implementation, use and User Satisfaction","volume":"11","author":"Hill-Kayser","year":"2009","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.radonc.2026.111570_b0045","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ejca.2016.07.007","article-title":"Cancer in Europe: death sentence or life sentence?","volume":"65","author":"Liu","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2026.111570_b0050","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrg3074","article-title":"Non-coding RNAs in human disease","volume":"12","author":"Esteller","year":"2011","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.radonc.2026.111570_b0055","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/bfgp\/elv055","article-title":"Noncoding RNAs in breast cancer","volume":"15","author":"Lo","year":"2016","journal-title":"Brief Funct Genomics"},{"key":"10.1016\/j.radonc.2026.111570_b0060","doi-asserted-by":"crossref","first-page":"3982","DOI":"10.3390\/ijms25073982","article-title":"Small Non-Coding RNAs and their Role in Locoregional Metastasis and Outcomes in Early-Stage Breast Cancer patients","volume":"25","author":"Escuin","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.radonc.2026.111570_b0070","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.3390\/ijms22063280","article-title":"Breast Cancer and the Other Non-Coding RNAs","volume":"22","author":"Dvorsk\u00e1","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.radonc.2026.111570_b0075","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/aps.2013.35","article-title":"Friend or foe: the role of microRNA in chemotherapy resistance","volume":"34","author":"Li","year":"2013","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.radonc.2026.111570_b0080","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3892\/mmr.2025.13619","article-title":"MicroRNAs: Novel clinical biomarkers for cancer radiotherapy (Review)","volume":"32","author":"Park","year":"2025","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.radonc.2026.111570_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111430","article-title":"Noncoding RNA network crosstalk in organ fibrosis","volume":"124","author":"Ling","year":"2024","journal-title":"Cell Signal"},{"key":"10.1016\/j.radonc.2026.111570_b0090","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12929-024-01013-w","article-title":"Metabolism-regulating non-coding RNAs in breast cancer: roles, mechanisms and clinical applications","volume":"31","author":"Xu","year":"2024","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.radonc.2026.111570_b0065","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2217\/epi.16.3","article-title":"Circular RNAs as a new field in gene regulation and their implications in translational research","volume":"8","author":"Vidal","year":"2016","journal-title":"Epigenomics"},{"key":"10.1016\/j.radonc.2026.111570_b0095","article-title":"Non-coding RNAs in cancer therapy-induced cardiotoxicity: Mechanisms, biomarkers, and treatments","volume":"9","author":"Sun","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.radonc.2026.111570_b0100","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.7150\/ijbs.58916","article-title":"Circular RNA circBCBM1 promotes breast cancer brain metastasis by modulating miR-125a\/BRD4 axis","volume":"17","author":"Fu","year":"2021","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.radonc.2026.111570_b0105","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20190621","article-title":"The emerging role of circular RNAs in breast cancer","volume":"39","author":"Zhou","year":"2019","journal-title":"Biosci Rep"},{"key":"10.1016\/j.radonc.2026.111570_b0110","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa022152","article-title":"Twenty-Year follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer","volume":"347","author":"Fisher","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2026.111570_b0115","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0140-6736(11)61625-5","volume":"379","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2026.111570_b0120","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of Axillary Dissection vs No Axillary Dissection on 10-Year overall Survival among Women with Invasive Breast Cancer and Sentinel Node Metastasis: the ACOSOG Z0011 (Alliance) Randomized Clinical Trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.radonc.2026.111570_b0125","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","article-title":"Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis","volume":"14","author":"DiSipio","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2026.111570_b0130","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S1470-2045(18)30378-4","article-title":"Quality of life and patient satisfaction after one-stage implant-based breast reconstruction with an acellular dermal matrix versus two-stage breast reconstruction (BRIOS): primary outcome of a randomised, controlled trial","volume":"19","author":"Negenborn","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2026.111570_b0135","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2459\/JCM.0000000000000667","article-title":"Chemotherapy-induced cardiotoxicity: new insights into mechanisms, monitoring, and prevention","volume":"19","author":"Cadeddu Dessalvi","year":"2018","journal-title":"J Cardiovasc Med"},{"key":"10.1016\/j.radonc.2026.111570_b0140","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00280-008-0876-6","article-title":"Central and peripheral nervous system toxicity of common chemotherapeutic agents","volume":"63","author":"Sioka","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.radonc.2026.111570_b0145","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3816\/CBC.2008.n.004","article-title":"Fertility and menopausal outcomes in young breast cancer survivors","volume":"8","author":"Partridge","year":"2008","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.radonc.2026.111570_b0150","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1093\/humrep\/dem027","article-title":"Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. potential mechanisms of ovarian injury","volume":"22","author":"Meirow","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.radonc.2026.111570_b0155","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa1803164","article-title":"Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer","volume":"379","author":"Francis","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2026.111570_b0160","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/jnci\/djr242","article-title":"Toxicity of Adjuvant Endocrine Therapy in Postmenopausal Breast Cancer patients: a Systematic Review and Meta-analysis","volume":"103","author":"Amir","year":"2011","journal-title":"JNCI: Journal of the National Cancer Institute"},{"key":"10.1016\/j.radonc.2026.111570_b0165","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1200\/JCO.2014.57.1547","article-title":"Randomized Exercise Trial of Aromatase Inhibitor\u2013Induced Arthralgia in Breast Cancer Survivors","volume":"33","author":"Irwin","year":"2015","journal-title":"JCO"},{"key":"10.1016\/j.radonc.2026.111570_b0170","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10549-024-07252-7","article-title":"Long-term effects of aromatase inhibitor withdrawal on bone mineral density in early breast cancer patients: 10-year follow-up results of the BREX study","volume":"206","author":"Blomqvist","year":"2024","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.radonc.2026.111570_b0175","doi-asserted-by":"crossref","unstructured":"Matthews A, Stanway S, Farmer RE, Strongman H, Thomas S, Lyon AR, et al. Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic review. BMJ 2018:k3845. 10.1136\/bmj.k3845.","DOI":"10.1136\/bmj.k3845"},{"key":"10.1016\/j.radonc.2026.111570_b0180","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","article-title":"Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer that Overexpresses HER2","volume":"344","author":"Slamon","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2026.111570_b0185","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s40265-024-02144-y","article-title":"Efficacy and Safety of CDK4\/6 Inhibitors: a Focus on HR+\/HER2\u2212 Early Breast Cancer","volume":"85","author":"Klocker","year":"2025","journal-title":"Drugs"},{"key":"10.1016\/j.radonc.2026.111570_b0190","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.3390\/biom13091422","article-title":"An Overview of the Safety Profile and Clinical Impact of CDK4\/6 Inhibitors in Breast Cancer\u2014A Systematic Review of Randomized phase II and III Clinical Trials","volume":"13","author":"Stanciu","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.radonc.2026.111570_b0195","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/jnci\/djae107","article-title":"Long-term cardiovascular disease risk after anthracycline and trastuzumab treatments in US breast cancer survivors","volume":"116","author":"Vo","year":"2024","journal-title":"JNCI: Journal of the National Cancer Institute"},{"key":"10.1016\/j.radonc.2026.111570_b0200","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jamacardio.2019.5586","article-title":"Long-term Cardiopulmonary Consequences of Treatment-Induced Cardiotoxicity in Survivors of ERBB2 -positive Breast Cancer","volume":"5","author":"Yu","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.radonc.2026.111570_b0205","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1470-2045(17)30904-X","article-title":"Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy","volume":"19","author":"Denkert","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2026.111570_b0210","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa2202809","article-title":"Pembrolizumab plus Chemotherapy in Advanced Triple-negative Breast Cancer","volume":"387","author":"Cortes","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2026.111570_b0215","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/jnci\/djab004","article-title":"Atezolizumab and nab-Paclitaxel in Advanced Triple-negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study","volume":"113","author":"Emens","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2026.111570_b0220","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for Early Triple-negative Breast Cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2026.111570_b0225","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-Related adverse events Associated with Immune Checkpoint Blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2026.111570_b0230","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","article-title":"Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials","volume":"366","author":"Clarke","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2026.111570_b0235","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2026.111570_b0240","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/nrc1950","article-title":"Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology","volume":"6","author":"Bentzen","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.radonc.2026.111570_b0245","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.radonc.2010.09.002","article-title":"Pathogenetic mechanisms in radiation fibrosis","volume":"97","author":"Yarnold","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111570_b0410","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jaad.2005.08.054","article-title":"Radiation dermatitis: Clinical presentation, pathophysiology, and treatment 2006","volume":"54","author":"Hymes","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.radonc.2026.111570_b0825","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/0360-3016(94)00422-H","article-title":"Late radiation injury to muscle and peripheral nerves","volume":"31","author":"Gillette","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111570_b0830","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ijrobp.2013.11.232","article-title":"The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: a prospective cohort study","volume":"88","author":"Warren","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111570_b0835","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1470-2045(05)70251-5","article-title":"Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries","volume":"6","author":"Darby","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2026.111570_b0840","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/hrt.2008.149088","article-title":"Radiation induced heart disease: systemic disorders in heart disease","volume":"95","author":"Heidenreich","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.radonc.2026.111570_b0845","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1016\/j.jacc.2017.09.1095","article-title":"Cardiovascular Complications of Cancer Therapy: best Practices in Diagnosis, Prevention, and Management: Part 2","volume":"70","author":"Chang","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.radonc.2026.111570_b0850","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.ijrobp.2006.08.058","article-title":"Radiation pneumonitis and fibrosis: mechanisms underlying its pathogenesis and implications for future research","volume":"66","author":"Tsoutsou","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111570_b0855","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/j.ijrobp.2009.05.070","article-title":"Radiation dose-volume effects in the esophagus","volume":"76","author":"Werner-Wasik","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111570_b0405","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.radonc.2004.08.021","article-title":"The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway","volume":"73","author":"Delanian","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111570_b0250","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/eye.1990.26","article-title":"Cephalic radiation and retinal vasculopathy","volume":"4","author":"Amoaku","year":"1990","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.radonc.2026.111570_b0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2012.04.025","article-title":"Relationship between irradiated breast volume and late normal tissue complications: a systematic review","volume":"104","author":"Mukesh","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111570_b0260","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1016\/S1470-2045(15)00417-9","article-title":"Radiotherapy in patients with connective tissue diseases","volume":"17","author":"Giaj-Levra","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2026.111570_b0265","doi-asserted-by":"crossref","first-page":"D1412","DOI":"10.2741\/Takeda","article-title":"Autoantibodies against DNA double-strand break repair proteins","volume":"6","author":"Takeda","year":"2001","journal-title":"Front Biosci"},{"key":"10.1016\/j.radonc.2026.111570_b0270","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.radonc.2007.11.031","article-title":"Chronic toxicity risk after radiotherapy for patients with systemic sclerosis (systemic scleroderma) or systemic lupus erythematosus: Association with connective tissue disorder severity","volume":"87","author":"Gold","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111570_b0275","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0167-8140(01)00429-7","article-title":"Consequential late effects in normal tissues","volume":"61","author":"D\u00f6rr","year":"2001","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111570_b0280","doi-asserted-by":"crossref","first-page":"e470","DOI":"10.1016\/j.cllc.2019.02.018","article-title":"Relationship between prior Radiotherapy and Checkpoint-Inhibitor Pneumonitis in patients with Advanced Non-Small-Cell Lung Cancer","volume":"20","author":"Voong","year":"2019","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.radonc.2026.111570_b0285","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ijrobp.2005.12.020","article-title":"Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized study","volume":"65","author":"Toledano","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111570_b0290","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/jnci\/88.13.918","article-title":"Radiotherapy-related lung fibrosis enhanced by tamoxifen","volume":"88","author":"Bentzen","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2026.111570_b0295","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/1748-717X-6-177","article-title":"Radiotherapy and \u201cnew\u201d drugs-new side effects?","volume":"6","author":"Niyazi","year":"2011","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111570_b0300","unstructured":"COPERNIC project investigators, Granzotto A, Benadjaoud MA, Vogin G, Devic C, Ferlazzo ML, et al. Influence of Nucleoshuttling of the ATM Protein in the Healthy Tissues Response to Radiation Therapy: Toward a Molecular Classification of Human Radiosensitivity. Int J Radiat Oncol Biol Phys 2016;94:450\u201360. 10.1016\/j.ijrobp.2015.11.013."},{"key":"10.1016\/j.radonc.2026.111570_b0305","doi-asserted-by":"crossref","first-page":"7426","DOI":"10.1158\/1078-0432.CCR-04-2634","article-title":"CD4 and CD8 T-lymphocyte apoptosis can predict radiation-induced late toxicity: a prospective study in 399 patients","volume":"11","author":"Ozsahin","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2026.111570_b0310","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0360-3016(00)00663-5","article-title":"A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003","volume":"48","author":"Fu","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111570_b0315","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijrobp.2003.10.018","article-title":"Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy","volume":"59","author":"Cowan","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111570_b0320","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nrclinonc.2012.203","article-title":"Past, present, and future of radiotherapy for the benefit of patients","volume":"10","author":"Thariat","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111570_b0325","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.semradonc.2006.11.003","article-title":"The role of functional imaging in the diagnosis and management of late normal tissue injury","volume":"17","author":"Evans","year":"2007","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111570_b0330","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.semradonc.2017.04.004","article-title":"Imaging Radiation-Induced Normal Tissue Injury to Quantify Regional Dose Response","volume":"27","author":"Fried","year":"2017","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111570_b0335","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0360-3016(98)00154-0","article-title":"Plasma transforming growth factor beta1 as a predictor of radiation pneumonitis","volume":"41","author":"Anscher","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111570_b0340","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2174\/1381612033455422","article-title":"ACE inhibitors and AII receptor antagonists in the treatment and prevention of bone marrow transplant nephropathy","volume":"9","author":"Moulder","year":"2003","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.radonc.2026.111570_b0345","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1524-475X.2009.00562.x","article-title":"Emerging therapy for improving wound repair of severe radiation burns using local bone marrow-derived stem cell administrations","volume":"18","author":"Bey","year":"2010","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.radonc.2026.111570_b0350","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1200\/JCO.2003.06.064","article-title":"Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis","volume":"21","author":"Delanian","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111570_b0355","first-page":"464","article-title":"Hyperbaric Oxygen Therapy and late Local toxic Effects in patients with Irradiated Breast Cancer: a Randomized Clinical Trial. JAMA","volume":"10","author":"Mink van der Molen","year":"2024","journal-title":"Oncol"},{"key":"10.1016\/j.radonc.2026.111570_b0360","article-title":"Interventions for Radiation-Induced Fibrosis in patients with Breast Cancer: Systematic Review and Meta-analyses","volume":"7","author":"Nogueira","year":"2022","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111570_b0365","doi-asserted-by":"crossref","first-page":"8394","DOI":"10.3390\/ijms26178394","article-title":"Fibrotic Disease of the Skin and Lung: Shared Pathways, Environmental Drivers, and Therapeutic Opportunities in a changing climate","volume":"26","author":"Grafanaki","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.radonc.2026.111570_b0370","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","article-title":"Fibrosis: from mechanisms to medicines","volume":"587","author":"Henderson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.radonc.2026.111570_b0375","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0360-3016(00)00435-1","article-title":"TGF-\u03b21 and radiation fibrosis: a master switch and a specific therapeutic target?","volume":"47","author":"Martin","year":"2000","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"10.1016\/j.radonc.2026.111570_b0380","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.semradonc.2006.11.005","article-title":"Responses of Normal Cells to Ionizing Radiation","volume":"17","author":"Rodemann","year":"2007","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111570_b0385","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.3390\/ijms24044004","article-title":"Fibrosis: Types, Effects, Markers, Mechanisms for Disease Progression, and its Relation with Oxidative stress, Immunity, and Inflammation","volume":"24","author":"Antar","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.radonc.2026.111570_b0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101530","article-title":"The interplay of fibroblasts, the extracellular matrix, and inflammation in scar formation","volume":"298","author":"Moretti","year":"2022","journal-title":"J Biol Chem"},{"key":"10.1016\/j.radonc.2026.111570_b0395","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ijrobp.2024.09.049","article-title":"Long Noncoding VIM-AS1: Biomarker of Breast Fibrosis Susceptibility after Radiation Therapy and Promoter of Transforming Growth factor Beta1-Driven Fibrosis","volume":"121","author":"Vinasco-Sandoval","year":"2025","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"10.1016\/j.radonc.2026.111570_b0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105089","article-title":"The clinical manifestations and molecular pathogenesis of radiation fibrosis","volume":"103","author":"Fijardo","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.radonc.2026.111570_b0415","doi-asserted-by":"crossref","first-page":"999","DOI":"10.4103\/jcrt.jcrt_1744_22","article-title":"Pulmonary fibrosis prevalence after adjuvant radiotherapy of iranian patients with breast cancer: a single-center cross-sectional study","volume":"20","author":"Rakhsha","year":"2024","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.radonc.2026.111570_b0420","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1080\/0284186X.2021.1976828","article-title":"Pneumonitis and fibrosis after breast cancer radiotherapy: occurrence and treatment-related predictors","volume":"60","author":"Karlsen","year":"2021","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2026.111570_b0425","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.ijrobp.2010.03.044","article-title":"Role of systemic therapy in the development of lung sequelae after conformal radiotherapy in breast cancer patients","volume":"80","author":"Varga","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111570_b0430","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.tranon.2018.09.009","article-title":"Advances in Molecular Mechanisms and Treatment of Radiation-Induced Pulmonary Fibrosis","volume":"12","author":"Chen","year":"2019","journal-title":"Transl Oncol"},{"key":"10.1016\/j.radonc.2026.111570_b0435","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.2174\/1389450111009011386","article-title":"Treatment for Radiation-Induced Pulmonary late Effects: Spoiled for Choice or looking in the wrong direction?","volume":"11","author":"Williams","year":"2010","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.radonc.2026.111570_b0440","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1084\/jem.20110551","article-title":"Integrating mechanisms of pulmonary fibrosis","volume":"208","author":"Wynn","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.radonc.2026.111570_b0445","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1742769","article-title":"Cardioprotection for radiation-induced heart disease in breast cancer patients","volume":"16","author":"M\u0119drek","year":"2026","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.radonc.2026.111570_b0450","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13014-023-02319-z","article-title":"Radiotherapy-induced diffuse myocardial fibrosis in early-stage breast cancer patients - multimodality imaging study with six-year follow-up","volume":"18","author":"Moisander","year":"2023","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111570_b0455","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/jama.2013.1363","article-title":"Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy","volume":"309","author":"Gulati","year":"2013","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.radonc.2026.111570_b0460","article-title":"Cardiac fibrosis in oncologic therapies","volume":"29","author":"Packard","year":"2022","journal-title":"Curr Opin Physiol"},{"key":"10.1016\/j.radonc.2026.111570_b0465","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3390\/life14080991","article-title":"Chemotherapy-Induced Peripheral Neuropathy: a recent Update on Pathophysiology and Treatment","volume":"14","author":"Mattar","year":"2024","journal-title":"Life"},{"key":"10.1016\/j.radonc.2026.111570_b0470","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4103\/0366-6999.172589","article-title":"Postmastectomy Pain: a Cross-sectional Study of Prevalence, Pain Characteristics, and Effects on Quality of Life","volume":"129","author":"Beyaz","year":"2016","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.radonc.2026.111570_b0475","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0167-8140(02)00060-9","article-title":"The radiotherapeutic injury \u2013 a complex \u2018wound.","volume":"63","author":"Denham","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2026.111570_b0480","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","article-title":"Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis","volume":"155","author":"Seretny","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.radonc.2026.111570_b0485","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jpra.2024.07.021","article-title":"Neuropathic Pain following Breast-conserving Surgery: a Systematic Review and Meta-Analysis","volume":"42","author":"Kwee","year":"2024","journal-title":"JPRAS Open"},{"key":"10.1016\/j.radonc.2026.111570_b0490","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3109\/02841869009096384","article-title":"Radiation-induced brachial plexus neuropathy in breast cancer patients","volume":"29","author":"Olsen","year":"1990","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2026.111570_b0495","article-title":"Inhibition of microRNA-155 Reduces Neuropathic Pain during Chemotherapeutic Bortezomib via Engagement of Neuroinflammation. Front","volume":"10","author":"Duan","year":"2020","journal-title":"Oncol"},{"key":"10.1016\/j.radonc.2026.111570_b0500","doi-asserted-by":"crossref","DOI":"10.1177\/15330338221127169","article-title":"A Multimodal Approach to Discover Biomarkers for Taxane-Induced Peripheral Neuropathy (TIPN): a Study Protocol","volume":"21","author":"Sharma","year":"2022","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.radonc.2026.111570_b0505","doi-asserted-by":"crossref","unstructured":"Sharma A, Johnson KB, Sen A, Bie B, Rhoades EE, Hershberger C, et al. Abstract P1-04-02: Longitudinal multi-omics study reveals potential targets against chemotherapy induced peripheral neuropathy during taxane treatment. Clin Cancer Res 2025;31:P1-04\u201302. 10.1158\/1557-3265.SABCS24-P1-04-02.","DOI":"10.1158\/1557-3265.SABCS24-P1-04-02"},{"key":"10.1016\/j.radonc.2026.111570_b0510","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s11064-021-03462-3","article-title":"MiR-30d Participates in Vincristine-Induced Neuropathic Pain by Down-Regulating GAD67","volume":"47","author":"Wang","year":"2022","journal-title":"Neurochem Res"},{"key":"10.1016\/j.radonc.2026.111570_b0515","doi-asserted-by":"crossref","first-page":"6804","DOI":"10.3390\/cimb45080430","article-title":"Identifying circRNA\u2013miRNA\u2013mRNA Regulatory Networks in Chemotherapy-Induced Peripheral Neuropathy","volume":"45","author":"Cao","year":"2023","journal-title":"Curr Issues Mol Biol"},{"key":"10.1016\/j.radonc.2026.111570_b0525","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12974-021-02098-y","article-title":"Transcriptome profiling of long noncoding RNAs and mRNAs in spinal cord of a rat model of paclitaxel-induced peripheral neuropathy identifies potential mechanisms mediating neuroinflammation and pain","volume":"18","author":"Li","year":"2021","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.radonc.2026.111570_b0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.145079","article-title":"Circ_0005075 targeting miR-151a-3p promotes neuropathic pain in CCI rats via inducing NOTCH2 expression","volume":"767","author":"Zhang","year":"2021","journal-title":"Gene"},{"key":"10.1016\/j.radonc.2026.111570_b0520","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12528","article-title":"Emerging roles of long non-coding RNAs in neuropathic pain","volume":"52","author":"Li","year":"2019","journal-title":"Cell Prolif"},{"key":"10.1016\/j.radonc.2026.111570_b0530","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111594","article-title":"Decreased microRNA-125a-3p contributes to upregulation of p38 MAPK in rat trigeminal ganglions with orofacial inflammatory pain","volume":"9","author":"Dong","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.radonc.2026.111570_b0535","doi-asserted-by":"crossref","unstructured":"Guo Y, Ma L, Zhang Z. circ_0013613 Promotes the recovery of spinal cord injury by regulating mir-370-3p\/caspase1 to regulate neuronal pyroptosis. Acta Biochim Pol 2023;70:91\u20137. 10.18388\/abp.2020_6244.","DOI":"10.18388\/abp.2020_6244"},{"key":"10.1016\/j.radonc.2026.111570_b0540","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1038\/s41467-019-12049-0","article-title":"CircAnks1a in the spinal cord regulates hypersensitivity in a rodent model of neuropathic pain","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.radonc.2026.111570_b0550","first-page":"704","volume":"12","author":"Pellegrini","year":"2020","journal-title":"MicroRNAs in Cancer Treatment-Induced Cardiotoxicity Cancers (Basel)"},{"key":"10.1016\/j.radonc.2026.111570_b0580","doi-asserted-by":"crossref","first-page":"11879","DOI":"10.1038\/s41598-017-12192-y","article-title":"Activation of miR-34a-5p\/Sirt1\/p66shc pathway contributes to doxorubicin-induced cardiotoxicity","volume":"7","author":"Zhu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.radonc.2026.111570_b0860","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1080\/15384101.2019.1673618","article-title":"miR-34b\/c regulates doxorubicin-induced myocardial cell injury through ITCH","volume":"18","author":"Zhang","year":"2019","journal-title":"Cell Cycle"},{"key":"10.1016\/j.radonc.2026.111570_b0865","doi-asserted-by":"crossref","unstructured":"Dodson C, Bilik SM, DiBartolomeo G, Pachalis H, Siegfried L, Johnson JAK, et al. A human ex vivo model of radiation-induced skin injury reveals p53-driven DNA damage signaling and recapitulates a TGF\u03b2 fibrotic response. bioRxiv 2025:2025.06.04.657901. 10.1101\/2025.06.04.657901.","DOI":"10.1101\/2025.06.04.657901"},{"key":"10.1016\/j.radonc.2026.111570_b0605","doi-asserted-by":"crossref","first-page":"7102","DOI":"10.3390\/ijms22137102","article-title":"Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Protect Cardiomyocytes from Doxorubicin-Induced Cardiomyopathy by Upregulating Survivin Expression via the miR-199a-3p-Akt-Sp1\/p53 Signaling Pathway","volume":"22","author":"Lee","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.radonc.2026.111570_b0615","doi-asserted-by":"crossref","unstructured":"Xia W, Chang B, Li L, Hu T, Ye J, Chen H, et al. MicroRNA therapy confers anti-senescent effects on doxorubicin-related cardiotoxicity by intracellular and paracrine signaling. Aging 2021;13:25256\u201370. 10.18632\/aging.203743.","DOI":"10.18632\/aging.203743"},{"key":"10.1016\/j.radonc.2026.111570_b0610","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2018.00734","article-title":"miR-499-5p Attenuates Mitochondrial Fission and Cell Apoptosis via p21 in Doxorubicin Cardiotoxicity","volume":"9","author":"Wan","year":"2019","journal-title":"Front Genet"},{"key":"10.1016\/j.radonc.2026.111570_b0870","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.redox.2017.12.013","article-title":"MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2","volume":"15","author":"Zhao","year":"2018","journal-title":"Redox Biol"},{"key":"10.1016\/j.radonc.2026.111570_b0875","doi-asserted-by":"crossref","unstructured":"Zhang H, Tian Y, Liang D, Fu Q, Jia L, Wu D, et al. The Effects of Inhibition of MicroRNA-375 in a Mouse Model of Doxorubicin-Induced Cardiac Toxicity. Med Sci Monit 2020;26:0\u20130. 10.12659\/MSM.920557.","DOI":"10.12659\/MSM.920557"},{"key":"10.1016\/j.radonc.2026.111570_b0880","doi-asserted-by":"crossref","first-page":"10710","DOI":"10.3390\/ijms221910710","article-title":"Pachymic Acid Attenuated Doxorubicin-Induced Heart failure by Suppressing miR-24 and Preserving Cardiac Junctophilin-2 in Rats","volume":"22","author":"Younis","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.radonc.2026.111570_b0885","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1111\/jcmm.14908","article-title":"MicroRNA-129-1-3p protects cardiomyocytes from pirarubicin-induced apoptosis by down-regulating the GRIN2D-mediated Ca2+ signalling pathway","volume":"24","author":"Li","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.radonc.2026.111570_b0595","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/tox.23438","article-title":"MiR-125b enhances doxorubicin-induced cardiotoxicity by suppressing the nucleus-cytoplasmic translocation of YAP via targeting STARD13","volume":"37","author":"Jin","year":"2022","journal-title":"Environ Toxicol"},{"key":"10.1016\/j.radonc.2026.111570_b9000","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.yjmcc.2020.02.009","article-title":"MicroRNA-31-5p attenuates doxorubicin-induced cardiotoxicity via quaking and circular RNA Pan3","volume":"140","author":"Ji","year":"2020","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.radonc.2026.111570_b0600","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ymthe.2018.11.004","article-title":"miR-212\/132 Cluster Modulation Prevents Doxorubicin-Mediated Atrophy and Cardiotoxicity","volume":"27","author":"Gupta","year":"2019","journal-title":"Mol Ther"},{"key":"10.1016\/j.radonc.2026.111570_b0585","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s11095-017-2194-3","article-title":"The Cardiotoxic Mechanism of Doxorubicin (DOX) and Pegylated Liposomal DOX in mice Bearing C-26 Colon Carcinoma: a Study Focused on microRNA Role for Toxicity Assessment of New Formulations","volume":"34","author":"Razavi-Azarkhiavi","year":"2017","journal-title":"Pharm Res"},{"key":"10.1016\/j.radonc.2026.111570_b0590","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cbi.2018.02.035","article-title":"Cardioprotective effect of paeonol against epirubicin-induced heart injury via regulating miR-1 and PI3K\/AKT pathway","volume":"286","author":"Wu","year":"2018","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.radonc.2026.111570_b0890","doi-asserted-by":"crossref","unstructured":"Chen X-T, Yu Y-H, Du Y-H, Xu L, Meng X-P. MiR-145-5p Attenuates Doxorubicin-Induced Heart Injury Through Targeting Cardiomyocyte Pyroptosis. Kaohsiung J Med Sci 2025:e70126. 10.1002\/kjm2.70126.","DOI":"10.1002\/kjm2.70126"},{"key":"10.1016\/j.radonc.2026.111570_b0895","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1512326","article-title":"miR-200a Attenuated Doxorubicin-Induced Cardiotoxicity through Upregulation of Nrf2 in mice","volume":"2019","author":"Hu","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.radonc.2026.111570_b0900","doi-asserted-by":"crossref","first-page":"e3020","DOI":"10.1038\/cddis.2017.409","article-title":"Doxorubicin upregulates CXCR4 via miR-200c\/ZEB1-dependent mechanism in human cardiac mesenchymal progenitor cells","volume":"8","author":"Beji","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.radonc.2026.111570_b0905","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/cvr\/cvq148","article-title":"Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway","volume":"87","author":"Horie","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.radonc.2026.111570_b0910","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217443","article-title":"Effect of radiotherapy on the expression of cardiovascular disease-related miRNA-146a, -155, -221 and -222 in blood of women with breast cancer","volume":"14","author":"Esplugas","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.radonc.2026.111570_b0915","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41419-019-1901-x","article-title":"miR-146a attenuates apoptosis and modulates autophagy by targeting TAF9b\/P53 pathway in doxorubicin-induced cardiotoxicity","volume":"10","author":"Pan","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.radonc.2026.111570_b0920","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2021.103624","article-title":"MicroRNA-98 ameliorates doxorubicin-induced cardiotoxicity via regulating caspase-8 dependent Fas\/RIP3 pathway","volume":"85","author":"Pan","year":"2021","journal-title":"Environ Toxicol Pharmacol"},{"key":"10.1016\/j.radonc.2026.111570_b0925","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.737826","article-title":"microRNA-377 Signaling Modulates Anticancer Drug-Induced Cardiotoxicity in mice","volume":"8","author":"Henderson","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.radonc.2026.111570_b0930","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/cdd.2014.187","article-title":"MicroRNA-221 inhibits autophagy and promotes heart failure by modulating the p27\/CDK2\/mTOR axis","volume":"22","author":"Su","year":"2015","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.radonc.2026.111570_b0575","doi-asserted-by":"crossref","first-page":"14511","DOI":"10.3390\/ijms160714511","article-title":"MiR-21 Protected Cardiomyocytes against Doxorubicin-Induced Apoptosis by Targeting BTG2","volume":"16","author":"Tong","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.radonc.2026.111570_b0710","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nature07511","article-title":"MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts","volume":"456","author":"Thum","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.radonc.2026.111570_b0935","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/597032","article-title":"MicroRNA-208a Silencing Attenuates Doxorubicin Induced Myocyte Apoptosis and Cardiac Dysfunction","volume":"2015","author":"Tony","year":"2015","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.radonc.2026.111570_b0715","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13075-016-0929-x","article-title":"MicroRNAs in fibrosis: opportunities and challenges","volume":"18","author":"O\u2019Reilly","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.radonc.2026.111570_b0730","doi-asserted-by":"crossref","first-page":"13027","DOI":"10.1073\/pnas.0805038105","article-title":"Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis","volume":"105","author":"van Rooij","year":"2008","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.radonc.2026.111570_b0940","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1165\/rcmb.2010-0323OC","article-title":"miR-29 is a Major Regulator of Genes Associated with Pulmonary Fibrosis","volume":"45","author":"Cushing","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.radonc.2026.111570_b0565","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1159\/000491896","article-title":"MicroRNA-29b Regulates the Mitochondria-Dependent Apoptotic Pathway by Targeting Bax in Doxorubicin Cardiotoxicity","volume":"48","author":"Jing","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.radonc.2026.111570_b0945","doi-asserted-by":"crossref","first-page":"e1754","DOI":"10.1038\/cddis.2015.89","article-title":"Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in \u03b2-adrenergic signaling and enhances apoptosis","volume":"6","author":"Roca-Alonso","year":"2015","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.radonc.2026.111570_b0795","article-title":"Epigenetic regulation in radiation-induced pulmonary fibrosis","author":"Li","year":"2023","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.radonc.2026.111570_b0950","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1748-717X-9-111","article-title":"Integrating microRNA and mRNA expression profiles in response to radiation-induced injury in rat lung","volume":"9","author":"Xie","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111570_b0555","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40959-022-00142-1","article-title":"A systematic review of miRNAs as biomarkers for chemotherapy-induced cardiotoxicity in breast cancer patients reveals potentially clinically informative panels as well as key challenges in miRNA research","volume":"8","author":"Brown","year":"2022","journal-title":"Cardio-Oncology"},{"key":"10.1016\/j.radonc.2026.111570_b0955","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1164\/rccm.201205-0888OC","article-title":"Epigenetic regulation of miR-17\u223c92 contributes to the pathogenesis of pulmonary fibrosis","volume":"187","author":"Dakhlallah","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.radonc.2026.111570_b0960","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.3892\/or.2014.3089","article-title":"MicroRNA expression profiles in human breast cancer cells after multifraction and single-dose radiation treatment","volume":"31","author":"Leung","year":"2014","journal-title":"Oncol Rep"},{"key":"10.1016\/j.radonc.2026.111570_b0965","article-title":"Dexrazoxane Protects Cardiomyocyte from Doxorubicin-Induced Apoptosis by Modulating miR-17-5p","volume":"2020","author":"Yu","year":"2020","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.radonc.2026.111570_b0970","doi-asserted-by":"crossref","unstructured":"Yin Z, Zhao Y, Li H, Yan M, Zhou L, Chen C, et al. miR-320a mediates doxorubicin-induced cardiotoxicity by targeting VEGF signal pathway. Aging 2016;8:192\u2013207. 10.18632\/aging.100876.","DOI":"10.18632\/aging.100876"},{"key":"10.1016\/j.radonc.2026.111570_b0630","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s10565-021-09660-7","article-title":"METTL14 promotes doxorubicin-induced cardiomyocyte ferroptosis by regulating the KCNQ1OT1-miR-7-5p-TFRC axis","volume":"39","author":"Zhuang","year":"2023","journal-title":"Cell Biol Toxicol"},{"key":"10.1016\/j.radonc.2026.111570_b0975","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2020.104480","article-title":"LncRNA KCNQ1OT1 contributes to cardiomyocyte apoptosis by targeting FUS in heart failure","volume":"115","author":"Lai","year":"2020","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.radonc.2026.111570_b0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcp.2019.101490","article-title":"lncRNA PVT1 aggravates doxorubicin-induced cardiomyocyte apoptosis by targeting the miR-187-3p\/AGO1 axis","volume":"49","author":"Zhan","year":"2020","journal-title":"Mol Cell Probes"},{"key":"10.1016\/j.radonc.2026.111570_b0980","doi-asserted-by":"crossref","unstructured":"Wu Y, Xiu W, Wu Y. Salvianolic Acid A Protects H9C2 Cardiomyocytes from Doxorubicin-Induced Damage by Inhibiting NFKB1 Expression Thereby Downregulating Long-Noncoding RNA (lncRNA) Plasmacytoma Variant Translocation 1 (PVT1). Med Sci Monit 2021;27:0\u20130. 10.12659\/MSM.929824.","DOI":"10.12659\/MSM.929824"},{"key":"10.1016\/j.radonc.2026.111570_b0625","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2147\/DDDT.S267474","article-title":"lt;]p>Long Noncoding RNA SOX2-OT Aggravates Doxorubicin-Induced Apoptosis of Cardiomyocyte by Targeting miR-942-5p\/DP5<\/p[gt;","volume":"15","author":"Wang","year":"2021","journal-title":"DDDT"},{"key":"10.1016\/j.radonc.2026.111570_b0985","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1016\/j.bbrc.2018.08.090","article-title":"Long noncoding RNA LINC00339 aggravates doxorubicin-induced cardiomyocyte apoptosis by targeting MiR-484","volume":"503","author":"Li","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.radonc.2026.111570_b0635","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.biopha.2016.04.017","article-title":"Obestatin attenuated doxorubicin-induced cardiomyopathy via enhancing long noncoding Mhrt RNA expression","volume":"81","author":"Li","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.radonc.2026.111570_b0650","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.omtn.2021.08.006","article-title":"Cardiomyocyte mitochondrial dynamic-related lncRNA 1 (CMDL-1) may serve as a potential therapeutic target in doxorubicin cardiotoxicity","volume":"25","author":"Aung","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.radonc.2026.111570_b0990","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1080\/09168451.2018.1553606","article-title":"LncRNA FOXC2-AS1 protects cardiomyocytes from doxorubicin-induced cardiotoxicity through activation of WNT1-inducible signaling pathway protein-1","volume":"83","author":"Zhang","year":"2019","journal-title":"Biosci Biotech Bioch"},{"key":"10.1016\/j.radonc.2026.111570_b0660","first-page":"2695","article-title":"Long intergenic non\u2011coding RNA\u2011p21 mediates cardiac senescence via the Wnt\/\u03b2\u2011catenin signaling pathway in doxorubicin-induced cardiotoxicity","volume":"17","author":"Xie","year":"2018","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.radonc.2026.111570_b0995","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s12272-020-01290-7","article-title":"Protective effect of lncRNA CRNDE on myocardial cell apoptosis in heart failure by regulating HMGB1 cytoplasm translocation through PARP-1","volume":"43","author":"Chen","year":"2020","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.radonc.2026.111570_b0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcp.2023.101937","article-title":"Long noncoding RNA RMRP ameliorates doxorubicin-induced apoptosis by interacting with PFN1 in a P53-Dependent manner","volume":"72","author":"Li","year":"2023","journal-title":"Mol Cell Probes"},{"key":"10.1016\/j.radonc.2026.111570_b0655","doi-asserted-by":"crossref","unstructured":"Xia W, Chang B, Li L, Hu T, Ye J, Chen H, et al. MicroRNA therapy confers anti-senescent effects on doxorubicin-related cardiotoxicity by intracellular and paracrine signaling. Aging 2021;13:25256\u201370. 10.18632\/aging.203743.","DOI":"10.18632\/aging.203743"},{"key":"10.1016\/j.radonc.2026.111570_b0765","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.153327","article-title":"Emerging role of non-coding RNAs in response of cancer cells to radiotherapy","volume":"218","author":"Ebahimzadeh","year":"2021","journal-title":"Pathology - Research and Practice"},{"key":"10.1016\/j.radonc.2026.111570_b1000","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102630","article-title":"Long non-coding RNA MALAT1: a crucial factor in fibrotic diseases","volume":"36","author":"Ran","year":"2025","journal-title":"Molecular Therapy Nucleic Acids"},{"key":"10.1016\/j.radonc.2026.111570_b0665","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1007\/s00204-019-02586-4","article-title":"Upregulation of let-7f-2-3p by long noncoding RNA NEAT1 inhibits XPO1-mediated HAX-1 nuclear export in both in vitro and in vivo rodent models of doxorubicin-induced cardiotoxicity","volume":"93","author":"Liu","year":"2019","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.radonc.2026.111570_b0770","article-title":"Radiotherapy and breast cancer: finally, an lncRNA perspective on radiosensitivity and radioresistance. Front","volume":"14","author":"Yazarlou","year":"2024","journal-title":"Oncol"},{"key":"10.1016\/j.radonc.2026.111570_b0680","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1161\/CIRCRESAHA.119.316061","article-title":"The Tumor-Suppressive Human Circular RNA CircITCH Sponges miR-330-5p to Ameliorate Doxorubicin-Induced Cardiotoxicity through Upregulating SIRT6, Survivin, and SERCA2a","volume":"127","author":"Han","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.radonc.2026.111570_b0670","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1536\/ihj.20-809","article-title":"Circ-SKA3 Enhances Doxorubicin Toxicity in AC16 Cells through miR-1303\/TLR4 Axis","volume":"62","author":"Li","year":"2021","journal-title":"Int Heart J"},{"key":"10.1016\/j.radonc.2026.111570_b0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118788","article-title":"Circular RNA Arhgap12 modulates doxorubicin-induced cardiotoxicity by sponging miR-135a-5p","volume":"265","author":"Wang","year":"2021","journal-title":"Life Sci"},{"key":"10.1016\/j.radonc.2026.111570_b0695","first-page":"1","article-title":"circFOXO3 protects cardiomyocytes against radiation\u2011induced cardiotoxicity","volume":"23","author":"Qiu","year":"2021","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.radonc.2026.111570_b1005","doi-asserted-by":"crossref","unstructured":"Aonuma T, Bayoumi AS, Tang Y, Kim I. A circular RNA regulator quaking: a novel gold mine to be unfolded in doxorubicin-mediated cardiotoxicity. Non-Coding RNA Investigation 2018;2. 10.21037\/ncri.2018.04.02.","DOI":"10.21037\/ncri.2018.04.02"},{"key":"10.1016\/j.radonc.2026.111570_b0640","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1093\/eurheartj\/ehv713","article-title":"A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223","volume":"37","author":"Wang","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.radonc.2026.111570_b0560","first-page":"2849","article-title":"Macrophage migration inhibitory factor serves a pivotal role in the regulation of radiation-induced cardiac senescencethrough rebalancing the microRNA-34a\/sirtuin 1 signaling pathway","volume":"42","author":"Hu","year":"2018","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.radonc.2026.111570_b0570","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0092-8674(93)90509-O","article-title":"Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death","volume":"74","author":"Oltval","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.radonc.2026.111570_b0685","first-page":"1402","article-title":"Foxo3 circular RNApromotes cardiac senescence by modulating multiple factors associated with stress and senescence responses","volume":"38","author":"Du","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.radonc.2026.111570_b0690","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.suronc.2018.06.003","article-title":"Role of non-coding RNAs in cardiotoxicity of chemotherapy","volume":"27","author":"Song","year":"2018","journal-title":"Surg Oncol"},{"key":"10.1016\/j.radonc.2026.111570_b0700","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/CIRCRESAHA.116.309568","article-title":"RBM20 Regulates Circular RNA Production from the Titin Gene","volume":"119","author":"Khan","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.radonc.2026.111570_b0705","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.yjmcc.2016.07.007","article-title":"Characterization of circular RNAs in human, mouse and rat hearts","volume":"98","author":"Werfel","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.radonc.2026.111570_b1010","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155557","article-title":"H2S inhibits atrial fibrillation-induced atrial fibrosis through miR-133a\/CTGF axis","volume":"146","author":"Su","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.radonc.2026.111570_b1015","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/ncb2126","article-title":"MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin\/NFAT signalling","volume":"12","author":"da Costa Martins","year":"2010","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.radonc.2026.111570_b0755","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ijmm.2021.4958","article-title":"MicroRNA\u2011133b alleviates doxorubicin\u2011induced cardiomyocyte apoptosis and cardiac fibrosis by targeting PTBP1 and TAGLN2","volume":"48","author":"Li","year":"2021","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.radonc.2026.111570_b1020","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3390\/genes14030702","volume":"14","author":"Mizielska","year":"2023","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.radonc.2026.111570_b1025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003291","article-title":"miR-199a-5p is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1","volume":"9","author":"Lino Cardenas","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/j.radonc.2026.111570_b1030","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.febslet.2012.12.027","article-title":"Differential roles of miR-199a-5p in radiation-induced autophagy in breast cancer cells","volume":"587","author":"Yi","year":"2013","journal-title":"FEBS Lett"},{"key":"10.1016\/j.radonc.2026.111570_b1035","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4135806","article-title":"Irradiated Human Umbilical Vein Endothelial Cells Undergo Endothelial-Mesenchymal transition via the Snail\/miR-199a-5p Axis to Promote the Differentiation of Fibroblasts into Myofibroblasts","volume":"2018","author":"Yi","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.radonc.2026.111570_b1040","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.4049\/jimmunol.1100591","article-title":"Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts","volume":"188","author":"Nakashima","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.radonc.2026.111570_b1045","doi-asserted-by":"crossref","unstructured":"Luo J, Chen J, He L. mir-129-5p Attenuates Irradiation-Induced Autophagy and Decreases Radioresistance of Breast Cancer Cells by Targeting HMGB1. Med Sci Monit 2015;21:4122\u20139. 10.12659\/msm.896661.","DOI":"10.12659\/MSM.896661"},{"key":"10.1016\/j.radonc.2026.111570_b0745","doi-asserted-by":"crossref","first-page":"e6718","DOI":"10.1371\/journal.pone.0006718","article-title":"Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: implication in epithelial-mesenchymal interactions","volume":"4","author":"Pottier","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.radonc.2026.111570_b1050","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2022.104758","article-title":"Expression level of miR-155, miR-15a and miR-19a in peripheral blood of ductal carcinoma breast cancer patients: possible bioindicators for cellular inherent radiosensitivity","volume":"126","author":"Rajabi","year":"2022","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.radonc.2026.111570_b1055","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108699","article-title":"MiRNA-155-5p inhibits epithelium-to-mesenchymal transition (EMT) by targeting GSK-3\u03b2 during radiation-induced pulmonary fibrosis","volume":"697","author":"Wang","year":"2021","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.radonc.2026.111570_b1060","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3390\/cells14070536","article-title":"Translational regulators in Pulmonary Fibrosis: MicroRNAs, Long Non-Coding RNAs, and Transcript modifications","volume":"14","author":"Gill","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.radonc.2026.111570_b0760","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020589","article-title":"Exosomal Micro\u2010RNA\u201096 Derived from Bone Marrow Mesenchymal Stem Cells Inhibits Doxorubicin\u2010Induced Myocardial Toxicity by Inhibiting the Rac1\/Nuclear Factor\u2010\u03baB Signaling Pathway","volume":"10","author":"Lei","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.radonc.2026.111570_b1065","doi-asserted-by":"crossref","first-page":"44132","DOI":"10.1038\/srep44132","article-title":"Changes in miRNA in the lung and whole blood after whole thorax irradiation in rats","volume":"7","author":"Gao","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.radonc.2026.111570_b1070","article-title":"Melatonin Alleviates Radiation-Induced Lung Injury via Regulation of miR-30e\/NLRP3 Axis","volume":"2019","author":"Wu","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.radonc.2026.111570_b1075","doi-asserted-by":"crossref","unstructured":"Shi S-J, Wang L-J, Yu B, Li Y-H, Jin Y, Bai X-Z. LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer. Oncotarget 2015;6:11652\u201363. 10.18632\/oncotarget.3457.","DOI":"10.18632\/oncotarget.3457"},{"key":"10.1016\/j.radonc.2026.111570_b1080","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1139\/bcb-2018-0168","article-title":"Down-regulation of lncRNA-ATB inhibits epithelial-mesenchymal transition of breast cancer cells by increasing miR-141-3p expression","volume":"97","author":"Zhang","year":"2019","journal-title":"Biochem Cell Biol"},{"key":"10.1016\/j.radonc.2026.111570_b1085","article-title":"Emerging roles of long non-coding RNAs in keloids. Front Cell","volume":"10","author":"Yu","year":"2022","journal-title":"Dev Biol"},{"key":"10.1016\/j.radonc.2026.111570_b1090","first-page":"e1848","article-title":"LINC01116 affects patient survival differently and is dissimilarly expressed in ER+ and ER- breast cancer samples","volume":"6","author":"Karimi Taheri","year":"2023","journal-title":"Cancer Rep (Hoboken)"},{"key":"10.1016\/j.radonc.2026.111570_b1095","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.3892\/mmr.2017.7163","article-title":"Long non\u2011coding RNA HOXA11\u2011AS promotes cell proliferation and metastasis in human breast cancer","volume":"16","author":"Su","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.radonc.2026.111570_b1100","doi-asserted-by":"crossref","first-page":"8309","DOI":"10.3390\/ijms23158309","article-title":"LncRNA H19 Impairs Chemo and Radiotherapy in Tumorigenesis","volume":"23","author":"Garcia-Padilla","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.radonc.2026.111570_b0785","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s00403-025-04200-3","article-title":"LINC01711 modulates proliferation, migration, and extracellular matrix deposition of hypertrophic scar fibroblasts by targeting miR-34a-5p","volume":"317","author":"Pan","year":"2025","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.radonc.2026.111570_b0780","doi-asserted-by":"crossref","DOI":"10.1016\/j.burns.2024.107353","article-title":"LINC00525 promotes cell proliferation and collagen expression through feedforward regulation of TGF-\u03b2 signaling in hypertrophic scar fibroblasts","volume":"51","author":"Chen","year":"2025","journal-title":"Burns"},{"key":"10.1016\/j.radonc.2026.111570_b1105","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1164\/rccm.201807-1237OC","article-title":"The Long Noncoding RNA DNM3OS is a Reservoir of FibromiRs with Major Functions in Lung Fibroblast Response to TGF-\u03b2 and Pulmonary Fibrosis","volume":"200","author":"Savary","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.radonc.2026.111570_b1110","article-title":"The Relationship between Differential Expression of Non-coding RNAs (TP53TG1, LINC00342, MALAT1, DNM3OS, miR-126-3p, miR-200a-3p, miR-18a-5p) and Protein-Coding Genes (PTEN, FOXO3) and risk of Idiopathic Pulmonary Fibrosis","author":"Korytina","year":"2025","journal-title":"Biochem Genet"},{"key":"10.1016\/j.radonc.2026.111570_b1115","doi-asserted-by":"crossref","unstructured":"Noroozpoor M, Mozdarani H, Rahbar Parvaneh R, Lashkari M. Evaluation of TP53TG1 and PANDA lncRNAs expression in association with adjuvant chemotherapy response in the peripheral blood of invasive ductal carcinoma patients. Cell Mol Biol (Noisy-Le-Grand) 2024;70:58\u201363. 10.14715\/cmb\/2024.70.10.9.","DOI":"10.14715\/cmb\/2024.70.10.9"},{"key":"10.1016\/j.radonc.2026.111570_b1120","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108354","article-title":"Lnc-Ang362 is a pro-fibrotic long non-coding RNA promoting cardiac fibrosis after myocardial infarction by suppressing Smad7","volume":"685","author":"Chen","year":"2020","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.radonc.2026.111570_b0775","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijcard.2022.06.073","article-title":"LncRNA HOTAIR promotes myocardial fibrosis in atrial fibrillation through binding with PTBP1 to increase the stability of Wnt5a","volume":"369","author":"Tan","year":"2022","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.radonc.2026.111570_b1125","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/annrheumdis-2019-216542","article-title":"Long non-coding RNA HOTAIR drives EZH2-dependent myofibroblast activation in systemic sclerosis through miRNA 34a-dependent activation of NOTCH","volume":"79","author":"Wasson","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.radonc.2026.111570_b1130","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s13075-020-02376-9","article-title":"Long non-coding RNA HOTAIR induces GLI2 expression through Notch signalling in systemic sclerosis dermal fibroblasts","volume":"22","author":"Wasson","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.radonc.2026.111570_b1135","article-title":"Construction and Analysis of a ceRNA Network in Cardiac Fibroblast during Fibrosis based on in vivo and in vitro Data","volume":"11","author":"Gao","year":"2020","journal-title":"Front Genet"},{"key":"10.1016\/j.radonc.2026.111570_b1140","article-title":"The emerging roles of LINC00511 in breast cancer development and therapy","volume":"14","author":"Zhao","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2026.111570_b0790","doi-asserted-by":"crossref","unstructured":"Yang X, Ni J, Li Y, Zou L, Guo T, Li Y, et al. LncRNA-RP11 Modulates TGF-\u03b21-Activated Radiation-Induced Lung Injury Through Downregulating microRNA-29a. Dose Response 2020;18:1559325820949071. 10.1177\/1559325820949071.","DOI":"10.1177\/1559325820949071"},{"key":"10.1016\/j.radonc.2026.111570_b1145","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3892\/ol.2014.2622","article-title":"Long intergenic non-coding RNA induced by X-ray irradiation regulates DNA damage response signaling in the human bronchial epithelial BEAS-2B cell line","volume":"9","author":"Jiao","year":"2015","journal-title":"Oncol Lett"},{"key":"10.1016\/j.radonc.2026.111570_b0805","doi-asserted-by":"crossref","first-page":"e9796","DOI":"10.7717\/peerj.9796","article-title":"CircHIPK3 regulates cardiac fibroblast proliferation, migration and phenotypic switching through the miR-152-3p\/TGF-\u03b22 axis under hypoxia","volume":"8","author":"Liu","year":"2020","journal-title":"PeerJ"},{"key":"10.1016\/j.radonc.2026.111570_b0810","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.7150\/ijbs.57915","article-title":"CircHIPK3 regulates pulmonary fibrosis by facilitating glycolysis in miR-30a-3p\/FOXK2-dependent manner","volume":"17","author":"Xu","year":"2021","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.radonc.2026.111570_b0815","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41419-019-1430-7","article-title":"circHIPK3 regulates lung fibroblast-to-myofibroblast transition by functioning as a competing endogenous RNA","volume":"10","author":"Zhang","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.radonc.2026.111570_b0800","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.3390\/ijms24021801","article-title":"Noncoding RNAs: Master Regulator of Fibroblast to Myofibroblast transition in Fibrosis","volume":"24","author":"Zhang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.radonc.2026.111570_b0820","doi-asserted-by":"crossref","unstructured":"Gu CY, Lee TKW. CircTUBD1: A Novel Circular RNA Molecule as a Therapeutic Target in Radiation-induced Liver Fibrosis. Journal of Clinical and Translational Hepatology 2022;10:571\u20133. 10.14218\/JCTH.2022.00132.","DOI":"10.14218\/JCTH.2022.00132"},{"key":"10.1016\/j.radonc.2026.111570_b1150","first-page":"3256","article-title":"Potential regulatory role of circular RNA in idiopathic pulmonary fibrosis","volume":"42","author":"Li","year":"2018","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.radonc.2026.111570_b1155","doi-asserted-by":"crossref","first-page":"40342","DOI":"10.1038\/srep40342","article-title":"CircRNA_000203 enhances the expression of fibrosis-associated genes by derepressing targets of miR-26b-5p, Col1a2 and CTGF, in cardiac fibroblasts","volume":"7","author":"Tang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.radonc.2026.111570_b1160","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.bbrc.2017.04.044","article-title":"A novel identified circular RNA, circRNA_010567, promotes myocardial fibrosis via suppressing miR-141 by targeting TGF-\u03b21","volume":"487","author":"Zhou","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.radonc.2026.111570_b0720","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijrobp.2014.05.003","article-title":"microRNA Alterations Driving Acute and late Stages of Radiation-Induced Fibrosis in a Murine Skin Model","volume":"90","author":"Simone","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2026.111570_b0725","doi-asserted-by":"crossref","first-page":"12250","DOI":"10.1038\/s41598-020-69038-3","article-title":"Cardioprotective effects of miR-34a silencing in a rat model of doxorubicin toxicity","volume":"10","author":"Piegari","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.radonc.2026.111570_b0735","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1111\/j.1742-4658.2010.07632.x","article-title":"MicroRNAs and the regulation of fibrosis","volume":"277","author":"Jiang","year":"2010","journal-title":"FEBS J"},{"key":"10.1016\/j.radonc.2026.111570_b0740","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/mt.2012.36","article-title":"miR-29 inhibits bleomycin-induced pulmonary fibrosis in mice","volume":"20","author":"Xiao","year":"2012","journal-title":"Mol Ther"},{"key":"10.1016\/j.radonc.2026.111570_b0750","doi-asserted-by":"crossref","unstructured":"Duisters RF, Tijsen AJ, Schroen B, Leenders JJ, Lentink V, van der Made I, et al. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ Res 2009;104:170\u20138, 6p following 178. 10.1161\/CIRCRESAHA.108.182535.","DOI":"10.1161\/CIRCRESAHA.108.182535"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026004093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814026004093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T21:43:32Z","timestamp":1783201412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814026004093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":233,"alternative-id":["S0167814026004093"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111570","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-coding (nc) RNAs and breast cancer treatment related sequelae: Current evidence and perspectives","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111570","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111570"}}